Steve Dubin
CIK: 0001265123
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACET
Adicet Bio, Inc.
Director
Discretionary Trading P&L
Holdings
About DUBIN STEVE
DUBIN STEVE (SEC CIK 0001265123) files insider reports with the SEC as Director of Adicet Bio, Inc. (ACET).
Signal8 holds 2 ownership filings by DUBIN STEVE, all Form 4s, filed between Jun 13, 2025 and Jun 23, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jun 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DUBIN STEVE's filings is in BOSTON, MA.
Recent filings by DUBIN STEVE
Other insiders filing for Adicet Bio, Inc. (ACET)
- Klickstein Lloyd, Chief Medical Officer
- Schor Chen, President & CEO
- Aftab Blake, Chief Scientific Officer
- Chodakewitz Jeffrey, Director
- Grissinger Michael, Director
- Sinclair Andrew, Director